According to Zhitong Finance App, Tiger Pharmaceuticals (03347.HK) issued an announcement. As of July 31, 2026, the company had repurchased 20.963 million shares of the company's shares through a special securities account for share repurchase through centralized bidding transactions, accounting for 2.4347% of the company's current total share capital and 2.8410% of the company's current total A-share capital. The highest transaction price was 42.78 yuan/share, the lowest transaction price was 38.22 yuan/share, and the total transaction amount was 824 million yuan (excluding transaction fees).

According to Zhitong Finance App, Tiger Pharmaceuticals (03347.HK) issued an announcement. As of July 31, 2026, the company had repurchased 20.963 million shares of the company's shares through a special securities account for share repurchase through centralized bidding transactions, accounting for 2.4347% of the company's current total share capital and 2.8410% of the company's current total A-share capital. The highest transaction price was 42.78 yuan/share, the lowest transaction price was 38.22 yuan/share, and the total transaction amount was 824 million yuan (excluding transaction fees).